(Reuters) -Britain’s health regulator said on Wednesday it has authorised Pfizer and BioNTech’s updated COVID-19 vaccine that targets the JN.1 subvariant for use in infants, children and adults.
The Medicines and Healthcare products Regulatory Agency (MHRA) said it has approved four forms of the adapted Comirnaty JN.1 vaccine after reviewing its safety, quality and effectiveness.
The regulator also said it would keep the safety of the vaccine under close review.
Globally, regulators like the European Medicines Agency and the World Health Organisation are recommending that COVID vaccine manufacturers update their vaccines to target the JN.1 variant, although the U.S. Food and Drug Administration suggested the targeting of the newer KP.2 variant, if feasible.
(Reporting by Unnamalai L in Bengaluru; Editing by Shounak Dasgupta and Shailesh Kuber)
